Norris Medicines

quarterly
yearly
ParticularsSep '23Dec '23Mar '24Jun '24Sep '24
Revenue2.560.651.520.731.27
Expenses3.040.921.251.101.63
EBITDA-0.25-0.040.52-0.15-0.15
EBIT-0.39-0.180.37-0.29-0.28
Profit Before Tax-0.48-0.270.26-0.37-0.36
Net Profit-0.48-0.270.17-0.37-0.36
Financial Ratios
Operating Profit Margin-9.77%-6.15%34.23%-20.83%-11.02%
Net Profit Margin-18.75%-41.54%11.41%-51.39%-28.35%
Earning Per Share (Diluted)-0.48-0.270.17-0.37-0.36
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ